CHMP Gives a Positive Opinion for the Use of VELCADE as Retreatment...

Janssen-Cilag International NV announced today that The Committee for Medical Products for Human Use of The European Medicines Agency has granted a positive opinion on two variations relating to the use of VELCADEA .1 VELCADEA is indicated for the treatment of multiple myeloma, a type of blood cancer.

http://www.businesswire.com/news/topix/20130628005393/en